Search

23 Feb 2024: DOI: 10.1038/s41598-017-12740-6. Martin J, Ponstingl H … Bradley A;Comprehensive annotation and evolutionary insights into the canine (Canis lupus familiaris) antigen receptor loci.

23 Feb 2024: We have shown that when naturally occurring polymorphisms render this “brake” ineffective, mice are predisposed to autoimmune diseases such as systemic lupus erythematosus (SLE). ... C Jolly, Richard Watts, Yu Lung Lau, Ann W Morgan, Gerard Nash,

23 Feb 2024: experiences – on medication adherence amongst lupus patients and indicates the clinician behaviours that help. ... Patients with Lupus and related diseases […]. Filed Under:Tagged With:December 14, 2020.

18 Dec 2023: This is particularly important when diagnostic tests in neuropsychiatric lupus are widely known to be “unenlightening”, according to one neurologist, in common with many other autoimmune diseases and long Covid. ... Attribution of neuropsychiatric

23 Feb 2024: How COVID-19-related healthcare changes affected patients with systemic autoimmune rheumatic diseases, including lupus. ... Filed Under:Tagged With:September 21, 2020. Lupus patients – and those with related systemic autoimmune diseases – often

23 Feb 2024: and Smith, K.G.C. “Local renal autoantibody production in lupus nephritis.” Journal of the American Society of Nephrology, 2011;22:296-305. ... and Macary, P.A. “Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus

23 Feb 2024: Primary Care Unit. Behavioural Science Group. Diagnostic delays for people with lupus described in new study. ... Paul Howard, Chief Executive of LUPUS UK. This research was funded by LUPUS UK.

23 Feb 2024: How lupus patients would like to be treated: study identifies physician behaviours that help build trust and medical security. ... September 21, 2020. Lupus patients – and those with related systemic autoimmune diseases – often experience persisting

23 Feb 2024: Site Search. Relationships with clinicians and adverse medical experiences affect medication adherence amongst lupus patients. ... Professor David D’Cruz, Consultant Rheumatologist, Louise Coote Lupus Unit at St Thomas’ Hospital.

23 Feb 2024: Site Search. ‘But you don’t look sick’: A qualitative analysis of the LUPUS UK forum. ... sick’: a qualitative analysis of the LUPUS UK online forum, published online, Rheumatology International, 27 October 2020.

23 Feb 2024: Site Search. ‘Inconsistent’ shielding guidance increases fears for vulnerable lupus patients during the pandemic. ... wide disparity in the communication and level of support received by lupus and related disease patients.

23 Feb 2024: Site Search. How lupus patients would like to be treated: study identifies physician behaviours that help build trust and medical security. ... September 21, 2020. Lupus patients – and those with related systemic autoimmune diseases – often

19 Feb 2024: of Cambridge to study the experiences of patients with lupus and related diseases. ... News COVID-19 lupus LUPUS UK Melanie Sloan https://www.phpc.cam.ac.uk/pcu/?p=21900 During the 2020 pandemic, patients with systemic autoimmune rheumatic diseases

23 Feb 2024: New research highlights the impact of current and past medical interactions – especially adverse experiences – on medication adherence amongst lupus patients and indicates the clinician behaviours that help. ... People with incurable systemic

23 Feb 2024: But you don’t look sick’: A qualitative analysis of the LUPUS UK forum. ... This in-depth analysis of the LUPUS UK forum, led by Melanie Sloan from the BSG and involving forum members, LUPUS UK, psychologists and leading rheumatologists, found

23 Feb 2024: Professor of Clinical Autoimmunity. Clinical evaluation of newer immunotherapeutics in vasculitis, lupus and immune-mediated renal disease.

24 Feb 2024: Primary Care Unit. Featured. March 8, 2021. Lupus patient experiences Lupus patients joined a research team at the University of Cambridge to study the experiences of patients with lupus and related ... diseases. Lupus is a chronic auto-immune condition

24 Feb 2024: with lupus report frequent lengthy time delays between their first symptoms and their lupus diagnosis, in new research from the University of Cambridge and LUPUS UK.

23 Feb 2024: David Jayne. Evaluates immunotherapeutics in vasculitis, lupus and immune-mediated renal disease and co-ordinates the European Vasculitis Study Group (EUVAS) and multi-centre randomised controlled trials.

24 Feb 2024: Scenarios where […]. Filed Under:Tagged With:July 19, 2021. New research highlights the impact of current and past medical interactions – especially adverse experiences – on medication adherence amongst lupus patients and indicates ... People with